AIMZERI Trademark

Prosecution Summary

Trademark Summary
AIMZERI is a standard character mark covering pharmaceutical preparations for the treatment of autoimmune, cardiovascular, endocrine, gastrointestinal, genetic, infectious, inflammatory, kidney, liver, menopausal, metabolic, musculoskeletal, neurodegenerative, neurological, neuromuscular, respiratory, and viral diseases and disorders in class 005, along with anti-infectives, medicated dermatological preparations, antifungal preparations, smoking cessation preparations, vaccines, and treatments for blood disorders, bone growth disorders, hormonal disorders, skin disorders, arthritis, cancer, cachexia, hypertension, migraine, pain, stroke, obesity, and diabetes, plus goods/services in classes 006, 018, 044, 046, 051, and 052. Owned by Pfizer Inc., a Delaware c

Trademark Facts

Goods & Services

Class 005: Pharmaceutical preparations for the treatment of autoimmune, cardiovascular, endocrine, gastrointestinal, genetic, infectious, inflammatory, kidney, liver, menopausal, metabolic, musculoskeletal, neurodegenerative, neurological, neuromuscular, respiratory, and viral diseases and disorder; Pharmaceuticals, namely, anti-infectives; Medicated dermatological preparations and substances; Antifungal preparations; Smoking cessation preparations; Vaccines for human use; Pharmaceutical preparations for the treatment of blood disorders, bone growth disorders, hormonal disorders, skin disorders, arthritis, cancer, cachexia, hypertension, migraine, pain, stroke, obesity and diabetes

Recent Prosecution Activity

USPTO Refusals on Record

• domicile_required
• improper_signature

Related

• All trademarks from Pfizer Inc.
• More marks in Class 005
• Search for similar marks to AIMZERI
• Run a clearance check
• Free USPTO trademark search